Biogen Appoints Michael J. Parini as Chief Legal Officer

Biogen Inc. (Nasdaq: BIIB) today announced the appointment of Michael J. Parini as Chief Legal Officer, effective August 3, 2026. Parini will serve as a member of Biogen's Executive Committee and report to Christopher A. Viehbacher, President and Chief Executive Officer. In this role, Mr. Parini will have responsibility for oversight of Biogen’s global legal and compliance functions.

Parini joins Biogen with more than 20 years of senior legal and strategic leadership experience across the biopharmaceutical and biotechnology industry. Most recently, he served as Chief Executive Officer of Spur Therapeutics, where he led a company transformation, redefining the scientific strategy and advancing a rare disease program from the pre-clinical stage into Phase 3 development. Prior to Spur Therapeutics, Parini held a series of leadership roles at Vertex Pharmaceuticals, rising to Chief Administrative, Legal and Business Development Officer, where he served on the Executive Committee and oversaw multiple functions spanning Legal, Compliance, Business Development, Human Resourc...